{"id":4142,"date":"2023-10-18T11:57:16","date_gmt":"2023-10-18T09:57:16","guid":{"rendered":"https:\/\/www.cvs-avocats.com\/apsalys-vulcain-engineering-1\/"},"modified":"2023-10-18T11:57:16","modified_gmt":"2023-10-18T09:57:16","slug":"apsalys-vulcain-engineering-1","status":"publish","type":"post","link":"https:\/\/www.cvs-avocats.com\/en\/apsalys-vulcain-engineering-1\/","title":{"rendered":"Cornet Vincent S\u00e9gurel assists the head of Apsalys in the takeover of the company by Vulcain Engineering"},"content":{"rendered":"<div class=\"section__body\">\n<div class=\"block-strong-text\">\n<p><p style=\"margin-left:0cm;margin-right:0cm\"><strong>Apsalys, a Bordeaux-based company specialising in quality control in the life sciences sector, has been taken over by Vulcain Engineering, an engineering group specialising in energy and pharmaceuticals. <\/strong><\/p>\n<\/p><\/div>\n<article class=\"article-normal\">\n<div class=\"article__entry\">\n<p>Philippe Charbon, CEO and founder of Apsalys, is handing over the reins ahead of his retirement at the end of the year. He is selling 100% of the capital of the Pessac-based company to the Vulcain Engineering group, backed by Equistone and Sagard. The financing of this transaction was arranged by D&amp;A Corporate Finance.<\/p>\n<p>Apsalys is a French company on a human scale (around ten employees), with a long history in the life sciences, regulatory and information systems markets. Its customers are small, medium-sized and large companies in the pharmaceutical, medical device and other regulated industries. It is involved in regulatory affairs, quality and market access for healthcare products, and provides a software solution to support the launch and marketing of healthcare products.<\/p>\n<p>Apsalys stands out in a niche market thanks to its exclusive partnership in France, Switzerland and Belgium with software publisher Master Control for e-QMS 5 (quality management systems) activities, distributing quality monitoring and control solutions for laboratories.<\/p>\n<p><u><strong>Participants:<\/strong><\/u><\/p>\n<p><strong>Vendor:<\/strong> Philippe Charbon (director and founder)<\/p>\n<p><strong><u>Acquirers <\/u><\/strong>:<\/p>\n<p><strong>&#8211; Vulcain Engineering:<\/strong> Fr&eacute;d&eacute;rique Grard, Alban Guilloteau<\/p>\n<p><strong>&#8211; Equistone Partners<\/strong><\/p>\n<p>&#8211; <strong>Sagard<\/strong><\/p>\n<p><u><strong>Advices :<\/strong><\/u><\/p>\n<p><strong>Attorney&nbsp;for the seller :<\/strong> Cornet Vincent S&eacute;guel (St&eacute;phanie G&eacute;rard)<\/p>\n<p><strong>M&amp;A Advisor to the seller <\/strong>: Clarfield International (Laurence d&#039;Halleine)<\/p>\n<p><strong>Purchasing attorneys: <\/strong>Lawderis Avocats (Faustine Carri&egrave;re, Bertrand Araud)<\/p>\n<p><strong>DD Financial Purchasers:<\/strong> KPMG TS (Yoann Lefort)<\/p>\n<p><strong>M&amp;A Advisory for the buyers:<\/strong> D&amp;A Partners (J&eacute;r&ocirc;me Da Silva, Fran&ccedil;ois Dubourg)<\/p>\n<\/p><\/div>\n<\/article><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Apsalys, a Bordeaux-based company specialising in quality control in the life sciences sector, has been taken over by Vulcain Engineering, an engineering group specialising in energy and pharmaceuticals. Philippe Charbon, CEO and founder of Apsalys, is handing over the reins ahead of his retirement at the end of the year. He is selling 100% of [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":4140,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[],"class_list":["post-4142","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communique-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/posts\/4142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/comments?post=4142"}],"version-history":[{"count":0,"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/posts\/4142\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/media\/4140"}],"wp:attachment":[{"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/media?parent=4142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/categories?post=4142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cvs-avocats.com\/en\/wp-json\/wp\/v2\/tags?post=4142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}